TENCENT
00700
TME-SW
01698
XIAOMI-W
01810
ALI HEALTH
00241
KUAISHOU-W
01024
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -180.79%-301.17M | ---- | 1,135.48%372.78M | ---- | -111.62%-36M | ---- | 844.80%309.79M | ---- | -86.43%32.79M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -589.05%-2.83M | ---- | -99.51%-411K | ---- | 69.02%-206K | ---- | -53.23%-665K | ---- | 41.03%-434K |
Attributable subsidiary (profit) loss | ---- | 1,164.27%5.1M | ---- | --403K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | 12,945.41%29.42M | ---- | -150.78%-229K | ---- | -25.33%451K | ---- | 62.37%604K | ---- | -98.02%372K |
-Impairment of property, plant and equipment (reversal) | ---- | --23.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 1,631.00%3.51M | ---- | -150.78%-229K | ---- | -25.33%451K | ---- | 62.37%604K | ---- | -98.02%372K |
-Other impairments and provisions | ---- | --2.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | 427.90%73.1M | ---- | 65.14%13.85M | ---- | -87.13%8.39M | ---- | 479.69%65.15M | ---- | -852.75%-17.16M |
-Fair value of investment properties (increase) | ---- | 772.44%65.4M | ---- | -214.05%-9.73M | ---- | -87.88%8.53M | ---- | 486.95%70.37M | ---- | -1,227.45%-18.19M |
-Other fair value changes | ---- | -67.35%7.7M | ---- | 16,584.62%23.57M | ---- | 97.26%-143K | ---- | -608.18%-5.22M | ---- | 338.28%1.03M |
Asset sale loss (gain): | ---- | -108.06%-35K | ---- | 125.94%434K | ---- | 99.56%-1.67M | ---- | -239,398.13%-383.2M | ---- | -125.20%-160K |
-Loss (gain) from sale of subsidiary company | ---- | --72K | ---- | ---- | ---- | 99.43%-2.17M | ---- | ---383.2M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -414.71%-107K | ---- | -92.09%34K | ---- | --430K | ---- | ---- | ---- | -125.20%-160K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 515.38%400K | ---- | --65K | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -39.40%2.69M | ---- | 29.12%4.43M | ---- | 20.53%3.43M | ---- | 2.45%2.85M | ---- | 1,152.70%2.78M |
Financial expense | ---- | 389.65%93.99M | ---- | -1.13%19.2M | ---- | -19.92%19.42M | ---- | -38.27%24.25M | ---- | -11.81%39.28M |
Unrealized exchange loss (gain) | ---- | 73.62%-2.49M | ---- | 8.94%-9.43M | ---- | -295.75%-10.36M | ---- | 221.10%5.29M | ---- | ---4.37M |
Special items | ---- | -700.00%-1.56M | ---- | -84.17%260K | ---- | 262.25%1.64M | ---- | ---1.01M | ---- | ---- |
Operating profit before the change of operating capital | ---- | -125.87%-103.8M | ---- | 2,791.58%401.29M | ---- | -164.65%-14.91M | ---- | -56.57%23.06M | ---- | -82.91%53.1M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 45.76%-2.04M | ---- | -284.10%-3.75M | ---- | 805.78%2.04M | ---- | 112.01%225K | ---- | ---1.87M |
Accounts receivable (increase)decrease | ---- | 426.64%7.47M | ---- | 107.32%1.42M | ---- | -75.34%-19.39M | ---- | -184.81%-11.06M | ---- | 78.21%-3.88M |
Accounts payable increase (decrease) | ---- | -167.41%-81.18M | ---- | 43.18%120.42M | ---- | 911.53%84.11M | ---- | -47.69%8.32M | ---- | -58.43%15.9M |
Special items for working capital changes | ---- | 224.50%1.04B | ---- | 134.83%320.52M | ---- | -1,089.19%-920.28M | ---- | 27.47%-77.39M | ---- | 87.00%-106.7M |
Cash from business operations | ---- | 2.46%860.57M | ---- | 196.71%839.9M | ---- | -1,427.69%-868.43M | ---- | -30.80%-56.85M | ---- | 91.13%-43.46M |
Other taxs | ---- | 57.17%-14.13M | ---- | -953.40%-32.98M | ---- | 94.59%-3.13M | ---- | -139.50%-57.84M | ---- | -9,919.92%-24.15M |
Special items of business | 6,006.09%451.58M | ---- | -109.64%-7.65M | ---- | 896.42%79.35M | ---- | 106.79%7.96M | ---- | ---117.27M | ---- |
Net cash from operations | 6,006.09%451.58M | 4.90%846.44M | -109.64%-7.65M | 192.58%806.92M | 896.42%79.35M | -659.99%-871.56M | 106.79%7.96M | -69.62%-114.68M | -25.37%-117.27M | 86.20%-67.61M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -81.74%308K | 589.05%2.83M | 2,495.38%1.69M | 99.51%411K | -38.68%65K | -69.02%206K | -68.36%106K | 53.23%665K | 165.87%335K | -41.03%434K |
Decrease in deposits (increase) | ---- | ---- | ---- | 1,931.82%403K | -187,544.44%-33.78M | 82.26%-22K | 73.13%-18K | 12.68%-124K | ---67K | -82.05%-142K |
Sale of fixed assets | -98.58%5K | --2.46M | --353K | ---- | ---- | --240K | ---- | ---- | ---- | --337K |
Purchase of fixed assets | 80.33%-142K | 84.56%-738K | -49.79%-722K | -204.33%-4.78M | -225.68%-482K | -123.47%-1.57M | 69.86%-148K | 51.75%-703K | -484.52%-491K | -235.71%-1.46M |
Sale of subsidiaries | ---- | --58M | ---- | ---- | ---- | -94.72%51.75M | ---- | --980M | --980M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --1.6M | ---- | ---- | ---49.38M |
Recovery of cash from investments | ---- | -81.16%1.46M | -73.63%1.79M | -59.13%7.77M | --6.8M | 319.52%19M | ---- | -45.28%4.53M | ---- | -66.35%8.28M |
Cash on investment | ---- | 99.34%-860K | ---- | -125.57%-131.13M | -163.80%-8.96M | -389.83%-58.13M | -109.83%-3.4M | 75.37%-11.87M | 90.01%-1.62M | -766.00%-48.19M |
Other items in the investment business | ---- | ---- | ---- | ---2.75M | ---- | ---- | ---- | ---42M | ---- | ---- |
Net cash from investment operations | -94.50%171K | 148.55%63.16M | 108.56%3.11M | -1,234.12%-130.08M | -1,855.30%-36.35M | -98.77%11.47M | -100.19%-1.86M | 1,132.47%930.5M | 8,744.03%978.16M | -567.96%-90.12M |
Net cash before financing | 10,061.43%451.75M | 34.39%909.6M | -110.55%-4.54M | 178.69%676.84M | 604.39%43M | -205.43%-860.09M | -99.29%6.1M | 617.21%815.82M | 921.04%860.89M | 66.49%-157.73M |
Cash flow from financing activities | ||||||||||
New borrowing | -97.13%16.53M | 56.18%1.27B | 158.63%576.05M | -44.31%810.14M | 202.63%222.73M | 249.42%1.45B | -39.10%73.6M | -58.34%416.3M | -65.11%120.86M | -47.20%999.3M |
Refund | -0.24%-405.1M | -39.32%-1.89B | -62.39%-404.15M | -161.18%-1.36B | -1,108.32%-248.88M | 57.33%-518.92M | 97.73%-20.6M | -66.90%-1.22B | -421.02%-907.17M | 41.41%-728.59M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.72M |
Interest paid - financing | -16.69%-119.53M | -28.16%-214.76M | -132.79%-102.43M | -99.03%-167.57M | -44.07%-44M | -0.06%-84.19M | 39.55%-30.54M | 24.21%-84.14M | -17.14%-50.52M | -54.34%-111.02M |
Dividends paid - financing | ---- | ---- | ---- | ---436K | ---- | ---- | ---- | 86.28%-14.11M | 98.71%-1.28M | -105.00%-102.86M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1.37%1.73M |
Other items of the financing business | 1,372.04%39.62M | -372.67%-61.43M | -108.65%-3.12M | -67.28%22.53M | -1.95%36.03M | 3.26%68.85M | 202.98%36.75M | 13.99%66.68M | --12.13M | --58.5M |
Net cash from financing operations | -951.61%-477.57M | -29.22%-919.73M | 228.25%56.08M | -178.95%-711.78M | -187.09%-43.73M | 206.29%901.51M | 106.02%50.21M | -878.04%-848.14M | -2,080.54%-834.2M | -79.39%109.01M |
Effect of rate | ---- | 71.38%-458K | ---- | 43.60%-1.6M | ---- | -12,995.45%-2.84M | ---- | 300.00%22K | ---- | 95.32%-11K |
Net Cash | -150.10%-25.82M | 71.02%-10.12M | 7,160.82%51.54M | -184.35%-34.94M | -101.30%-730K | 228.14%41.42M | 110.99%56.31M | 33.66%-32.32M | 142.54%26.69M | -183.80%-48.72M |
Begining period cash | -18.40%46.92M | -38.85%57.5M | -38.85%57.5M | 69.57%94.04M | 69.57%94.04M | -36.81%55.46M | -36.81%55.46M | -35.70%87.76M | -27.69%87.76M | 115.07%136.49M |
Cash at the end | -80.65%21.1M | -18.40%46.92M | 16.86%109.05M | -38.85%57.5M | -16.51%93.31M | 69.57%94.04M | -2.34%111.77M | -36.81%55.46M | 96.59%114.45M | -27.69%87.76M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.